Agency Information Collection Activities: Submission for OMB Review; Comment Request
| Published date | 07 October 2021 |
| Citation | 86 FR 55853 |
| Record Number | 2021-21965 |
| Section | Notices |
| Court | Substance Abuse And Mental Health Services Administration |
55853
Federal Register / Vol. 86, No. 192 / Thursday, October 7, 2021 / Notices
1
United States Government Accountability
Office. (2020, November). Drug Misuse: Agencies
Have Not Fully Identified How Grants That Can
Support Drug Prevention Education Programs
Contribute to National Goals. https://www.gao.gov/
assets/gao-21-96.pdf.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Ovarian Physiology.
Date: November 1, 2021.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6701 Rockledge Drive, Room 2131B,
Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Luis E. Dettin, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2131B,
Bethesda, MD 20892, 301–827–8231,
luis.dettin@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.865, Research for Mothers
and Children, National Institutes of Health,
HHS)
Dated: October 4, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–21903 Filed 10–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Population Sciences Study
Section.
Date: October 18, 2021.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2121B,
Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Christiane M. Robbins,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Rm. 2121B,
Bethesda, MD 20892, (301) 451–4989,
crobbins@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Archiving and
Documenting Child Health and Human
Development Data Sets.
Date: October 18, 2021.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2121B,
Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Christiane M. Robbins,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2121B,
Bethesda, MD 20892, 301–451–4989,
crobbins@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children,
National Institutes of Health, HHS)
Dated: October 4, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–21899 Filed 10–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act. To request a
copy of these documents, call the
SAMHSA Reports Clearance Officer at
(240) 276–0361.
Project: State Opioid Response (SOR)/
Tribal Opioid Response (TOR) Program
Instrument (OMB No. 0930–0384)—
Revision
SAMHSA is requesting approval to
modify its existing CSAT SOR/TOR
Program Instrument by (1) collapsing
the original three questions into two
questions for clarity and (2) adding ten
questions in order to collect information
on Congressionally mandated and
programmatic activities, and comply
with reporting requirements. The
program-level information is collected
quarterly and entered and stored in
SAMHSA’s Performance Accountability
and Reporting System, which is a real-
time, performance management system
that captures information on the
substance use prevention and treatment
and mental health services delivered in
the United States. Continued approval
of this information collection will allow
SAMHSA to continue to meet
Government Performance and Results
Modernization Act of 2010 reporting
requirements that quantify the effects
and accomplishments of its
discretionary grant programs.
The SOR/TOR programs were first
authorized under Title II Division H of
the Consolidated Appropriations Act,
2018, Public Law 115–141. SAMHSA
anticipates 159 recipients (states,
territories, and tribal entities) will
participate in these grant programs.
Grantee-level data will include
information related to: Reported
overdose reversals; the purchase and
distribution of naloxone; training in the
administration of naloxone;
implementation of prevention and
education activities; outreach activities
for underserved communities; and the
purchase and distribution of fentanyl
test strips. This grantee-level
information will be collected quarterly.
The revisions to the tool will enable
SAMHSA to better assess grantee
accountability and performance on the
required education and prevention
activities for the SOR/TOR programs.
SAMHSA will also use the data
collected through the revised tool to
implement recommendations resulting
from the GAO study, ‘‘Drug Misuse:
Agencies Have Not Fully Identified How
Grants That Can Support Drug
Prevention Education Programs
Contribute to National Goals (GAO–21–
96).
1
Finally, the revisions will assist
SAMHSA in providing comprehensive
VerDate Sep<11>2014 17:46 Oct 06, 2021 Jkt 256001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\07OCN1.SGM 07OCN1
lotter on DSK11XQN23PROD with NOTICES1
55854
Federal Register / Vol. 86, No. 192 / Thursday, October 7, 2021 / Notices
data on the full range of required
activities to inform Congressionally
mandated reports for the SOR program.
CSAT anticipates that the time
required to collect and report the
program-level information is
approximately 18 minutes per response.
Since the submission of the original
OMB package, there has been a
reduction in the number of respondents.
The estimated burden associated with
the program-level instrument includes
an adjustment to reflect the current
number of grantees.
T
ABLE
1—E
STIMATE OF
A
NNUALIZED
H
OUR
B
URDEN FOR
SOR/TOR G
RANTEES
SAMHSA data collection Number of
respondents Responses
per respondent Total number
of responses Burden hours
per response Total burden
hours Hourly wage
1
Total wage
cost
Grantee-Level Instrument ........................... 159 4 636 .30 190.80 $24.78 $4,728.02
CSAT Total .......................................... 159 4 636 .30 190.80 24.78 4,728.02
1
The hourly wage estimate is $24.78 based on the Occupational Employment and Wages, Mean Hourly Wage Rate for 21–1018 Substance Abuse, Behavioral Dis-
order, and Mental Health Counselors = $24.78/hr. as of May 2020 (https://www.bls.gov/oes/current/oes211018.htm Accessed on May 4, 2021.).
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2021–21965 Filed 10–6–21; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–0361.
Project: Opioid Drugs in Maintenance
and Detoxification Treatment of Opioid
Dependence—42 CFR Part 8 (OMB No.
0930–0206) and Opioid Treatment
Programs (OTPs)—Extension
42 CFR part 8 establishes a
certification program managed by
SAMHSA’s Center for Substance Abuse
Treatment (CSAT). The regulation
requires that Opioid Treatment
Programs (OTPs) be certified.
‘‘Certification’’ is the process by which
SAMHSA determines that an OTP is
qualified to provide opioid treatment
under the Federal opioid treatment
standards established by the Secretary
of Health and Human Services. To
become certified, an OTP must be
accredited by a SAMHSA-approved
accreditation body. The regulation also
provides standards for such services as
individualized treatment planning,
increased medical supervision, and
assessment of patient outcomes. This
submission seeks continued approval of
the information collection requirements
in the regulation and of the forms used
in implementing the regulation.
SAMHSA currently has approval for
the Application for Certification to Use
Opioid Drugs in a Treatment Program
Under 42 CFR 8.11 (Form SMA–162);
the Application for Approval as
Accreditation Body Under 42 CFR 8.3(b)
(Form SMA–163); and the Exception
Request and Record of Justification
Under 42 CFR 8.12 (Form SMA–168),
which may be used on a voluntary basis
by physicians when there is a patient
care situation in which the physician
must make a treatment decision that
differs from the treatment regimen
required by the regulation. Form SMA–
168 is a simplified, standardized form to
facilitate the documentation, request,
and approval process for exceptions.
SAMHSA believes that the
recordkeeping requirements in the
regulation are customary and usual
practices within the medical and
rehabilitative communities and has not
calculated a response burden for them.
The recordkeeping requirements set
forth in 42 CFR 8.4, 8.11 and 8.12
include maintenance of the following: 5-
year retention by accreditation bodies of
certain records pertaining to
accreditation; documentation by an OTP
of the following: A patient’s medical
examination when admitted to
treatment, a patient’s history, a
treatment plan, any prenatal support
provided the patient, justification of
unusually large initial doses, changes in
a patient’s dosage schedule, justification
of unusually large daily doses, the
rationale for decreasing a patient’s clinic
attendance, and documentation of
physiologic dependence.
The table that follows summarizes the
annual reporting burden associated with
the regulation, including burden
associated with the forms. There are no
changes being made to the forms.
Form Number of
respondents Responses/
respondent Total
responses Hours/
response Total hours
Estimated Annual Reporting Requirement Burden for Accreditation Bodies
SMA–163 ............................................................................. 54 26.055 1,407 0.28 394
Estimated Annual Reporting Requirement Burden for Opioid Treatment Programs
SMA–162 ............................................................................. 651.33 17.976 11,708.91 ........................ ........................
SMA–168 ............................................................................. 1,302.67 17.977 23,418.09 ........................ ........................
Subtotal ......................................................................... 1954 17.977 35,127 0.08 2902
Total ....................................................................... ........................ ........................ 36,534 ........................ 3296
VerDate Sep<11>2014 17:46 Oct 06, 2021 Jkt 256001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\07OCN1.SGM 07OCN1
lotter on DSK11XQN23PROD with NOTICES1
